Market Research Logo

Mucopolysaccharidosis (MPS) Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Mucopolysaccharidosis (MPS) Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

A recent market study published by PMR– “Mucopolysaccharidosis Treatment Market: Global Industry Analysis 2014-2018 & Forecast, 2019-2029” consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research of the historic as well as current growth parameters of the mucopolysaccharidosis treatment market, the growth prospects are obtained with maximum precision.

The mucopolysaccharidosis treatment market report features the unique and salient factors that are likely to significantly impact the development of the mucopolysaccharidosis treatment market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the mucopolysaccharidosis treatment market in the upcoming years. The report provides detailed information about the current and future growth prospects of the mucopolysaccharidosis treatment market in the most comprehensive manner for the better understanding of readers.

Chapter 1 – Executive Summary

The mucopolysaccharidosis treatment market report commences with an executive summary of the key findings and key statistics of the Mucopolysaccharidosis Treatment market. It also includes the market value (US$ million) estimates of the leading segments of the mucopolysaccharidosis treatment market.

Chapter 2 – Market Overview

Readers can find detailed market taxonomy which highlights the inclusions and exclusions for the subject. The definition of mucopolysaccharidosis treatment market is included in this chapter, which helps in understanding the basic information about the concerned mucopolysaccharidosis treatment market, which helps the reader understand the scope of the mucopolysaccharidosis treatment market report.

Chapter 3 – Key Trends

This section explains about the key trends followed by the manufacturer and consumer in mucopolysaccharidosis treatment market. This section helps reader to understand the both supply-side and demand-side trend impacting the growth of mucopolysaccharidosis treatment market.

Chapter 4 – Key Success Factors

This chapter highlights the key success factors of the mucopolysaccharidosis treatment market, which include regulatory scenario, pipeline analysis, snapshot of developments for mucopolysaccharidosis Type 3, rare disease framework and designed designation for each treatment present.

Chapter 5 – Global Mucopolysaccharidosis Treatment Market Value Analysis 2014-2018 & Forecast, 2019-2029

This section explain the global market analysis and forecast for the mucopolysaccharidosis treatment market. It also highlights the incremental opportunity for the mucopolysaccharidosis treatment market along with the absolute dollar opportunity for every year between the forecast period of 2019-2029.

Chapter 6 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the mucopolysaccharidosis treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the mucopolysaccharidosis treatment market. This chapter also highlights the key dynamics of the mucopolysaccharidosis treatment market, which include the drivers and restraints.

Chapter 7 – Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029, By Treatment Type

Based on the Treatment Type, the mucopolysaccharidosis treatment market is segmented into Enzyme Replacement Therapies and Stem Cell Therapies. Stem Cell Therapies is further segmented into Bone Marrow Transplantation and Umbilical Cord Blood Transplantation. In this chapter, readers can find a detailed analysis of the mucopolysaccharidosis treatment market by different Treatment Type and their expected growth over the forecast period.

Chapter 8 – Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029, By Type of MPS

Based on the Type of MPS, the mucopolysaccharidosis treatment market is segmented into MPS I, MPS II, MPS IV A, MPS VI and MPS VII. This section helps readers understand the prevalence of different Type of MPS in the mucopolysaccharidosis treatment market over the forecast period.

Chapter 9 – Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029, By End User

Based on end user, the mucopolysaccharidosis treatment market is segmented into Hospital, Specialty Clinics, Medical Research Centers and Home-infusion. In this chapter, readers can also understand the market attractive analysis based on the end user.

Chapter 10 – Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029, By Region

This chapter explains how the mucopolysaccharidosis treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa (MEA).

Chapter 11 – North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

This chapter includes a detailed analysis of the growth of the North America mucopolysaccharidosis treatment market along with a country-wise assessment, which includes the U.S. and Canada. Readers can also find the key takeaways of this region, and market growth based on treatment type, type of MPS, end user and country of mucopolysaccharidosis treatment in the North America region.

Chapter 12 – Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

This chapter contains a snapshot of the Latin America mucopolysaccharidosis treatment market. It includes the growth prospects of the mucopolysaccharidosis treatment market in the leading LATAM countries such as Brazil, Mexico, Argentina and the rest of the Latin America region.

Chapter 13 –Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

The important growth prospects of the mucopolysaccharidosis treatment market based on treatment type, type of MPS and end user in several European countries, such as the U.K., Germany, France, Italy, Spain, Russia and the rest of Western Europe, is included in this chapter.

Chapter 14 –East Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

This chapter highlights the growth of the mucopolysaccharidosis treatment market in Eastern Europe by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the mucopolysaccharidosis treatment market in East Asia.

Chapter 15 – South Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia mucopolysaccharidosis treatment market in this chapter. Readers can find detailed information about the growth parameters of the South Asia mucopolysaccharidosis treatment market during the period 2019-2029.

Chapter 16 – Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

Readers can find important factors that can significantly impact the growth of the mucopolysaccharidosis treatment market in Australia and New Zealand during the forecast period based on the market segmentation.

Chapter 17 – MEA Mucopolysaccharidosis Treatment Market Analysis 2014-2018 & Forecast, 2019-2029

This chapter provides information about the growth of the mucopolysaccharidosis treatment market in the major countries of the MEA region, such as GCC Countries and South Africa, during the period 2019-2029.

Chapter 18 – Market Structure Analysis

This section explains the tier structure for global mucopolysaccharidosis treatment market which helps reader to understand the percent share of market cover by tier 1, tier 2, and tier 3 players in the mucopolysaccharidosis treatment market. This section also explains the company share analysis for mucopolysaccharidosis treatment market which helps readers to understand the market share taken by key players available in the market.

Chapter 19 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the mucopolysaccharidosis treatment market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the players featured in the mucopolysaccharidosis treatment market report are Sanofi S.A., Shire, BioMarin Pharmaceutical Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., ArmaGen, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva.

Chapter 20 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 21 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the mucopolysaccharidosis treatment market.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Technological Developments
4. Key Success Factors
4.1. Regulatory Scenario
4.2. Pipeline Analysis
4.3. Snapshot of Developments for Mucopolysaccharidosis Type 3
4.4. Designed Designation
4.5. Rare Disease Framework
5. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Expenditure Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Improved Services in Concerned Economies
6.2.2. Drug Candidates in Pipeline
6.2.3. Drug Approval Process in Different Economies
6.2.4. Growth in Production Capacity
6.2.5. Change in Cost of Treatment
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014 - 2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 - 2029
7.3.1. Enzyme Replacement Therapies
7.3.2. Stem Cell Therapies
7.3.2.1. Bone Marrow Transplantation (BMT)
7.3.2.2. Umbilical Cord Blood Transplantation (UCBT)
7.4. Market Attractiveness Analysis By Treatment Type
8. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Type of MPS
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Type of MPS, 2014 - 2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type of MPS, 2019 - 2029
8.3.1. MPS I
8.3.2. MPS II
8.3.3. MPS IV A
8.3.4. MPS VI
8.3.5. MPS VII
8.4. Market Attractiveness Analysis By Type of MPS
9. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 - 2029
9.3.1. Hospital
9.3.2. Specialty Clinics
9.3.3. Medical Research Centers
9.3.4. Home-infusion
9.4. Market Attractiveness Analysis By End User
10. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. MEA
10.3.7. Oceania
10.4. Market Attractiveness Analysis By Region
11. North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Treatment Type
11.3.3. By Type of MPS
11.3.4. By End User
11.4. Market Attractiveness Analysis
12. Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Treatment Type
12.3.3. By Type of MPS
12.3.4. By End User
12.4. Market Attractiveness Analysis
13. Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Treatment Type
13.3.3. By Type of MPS
13.3.4. By End User
13.4. Market Attractiveness Analysis
14. South Asia Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Treatment Type
14.3.3. By Type of MPS
14.3.4. By End User
14.4. Market Attractiveness Analysis
15. East Asia Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Treatment Type
15.3.3. By Type of MPS
15.3.4. By End User
15.4. Market Attractiveness Analysis
16. Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Treatment Type
16.3.3. By Type of MPS
16.3.4. By End User
16.4. Market Attractiveness Analysis
17. Middle East and Africa Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. South Africa
17.3.1.3. Rest of Middle East and Africa
17.3.2. By Treatment Type
17.3.3. By Type of MPS
17.3.4. By End User
17.4. Market Attractiveness Analysis
18. Market Structure Analysis
18.1. Market Share Analysis
18.2. Competition Mapping
19. Competition Analysis
19.1. Company Dashboard
19.2. Company Profile
19.2.1. Sanofi S.A.
19.2.1.1. Overview
19.2.1.2. Service Portfolio
19.2.1.3. Analyst Commentary
19.2.2. Shire
19.2.3. BioMarin Pharmaceutical Inc.
19.2.4. Ultragenyx Pharmaceutical Inc.
19.2.5. Sarepta Therapeutics
19.2.6. Abeona Therapeutics, Inc.
19.2.7. ArmaGen
19.2.8. Eloxx Pharmaceuticals
19.2.9. Esteve
19.2.10. Immusoft Corporation
19.2.11. Inventiva
19.2.12. Orchard Therapeutics Limited
19.2.13. REGENXBIO Inc.
19.2.14. Sangamo Therapeutics, Inc.
20. Assumptions and Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report